id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1981-N-0012-0052,FDA,FDA-1981-N-0012,FDA/OC to Wyeth Consumer Healthcare (Arnold & Porter LLP) - Letter,Other,Letter(s),2011-07-20T04:00:00Z,2011,7,2011-07-20T04:00:00Z,,2011-07-20T19:32:17Z,,0,0,0900006480ec707a
FDA-1981-N-0012-0050,FDA,FDA-1981-N-0012,"Reference 10 - LET84, 1981N-0022  [Notice of Proposed Rule Published 3/9/2011]",Supporting & Related Material,N-Notice (Supporting and Related Material),2011-03-11T05:00:00Z,2011,3,,,2011-03-11T15:52:26Z,,0,0,0900006480c05685
FDA-1981-N-0012-0045,FDA,FDA-1981-N-0012,List of References to the Proposed Rule of 3/9/2011,Supporting & Related Material,N-Notice (Supporting and Related Material),2011-03-10T05:00:00Z,2011,3,,,2011-03-10T21:05:42Z,,0,0,0900006480c05600
FDA-1981-N-0012-0047,FDA,FDA-1981-N-0012,"Reference 7 - LET82, 1981N-0022   [Notice of Proposed Rule Published 3/9/2011]",Supporting & Related Material,N-Notice (Supporting and Related Material),2011-03-10T05:00:00Z,2011,3,,,2011-03-10T22:12:03Z,,0,0,0900006480c05680
FDA-1981-N-0012-0046,FDA,FDA-1981-N-0012,"Reference 1 -  FDA, “Draft Guidance for Industry--Developing Products for Weight Management,” February 2007 [Notice of Proposed Rule Published 3/9/2011]",Supporting & Related Material,N-Notice (Supporting and Related Material),2011-03-10T05:00:00Z,2011,3,,,2011-03-10T21:07:15Z,,0,0,0900006480c05602
FDA-1981-N-0012-0048,FDA,FDA-1981-N-0012,"Reference 8 -  LET87, 1981N-0022  [Notice of Proposed Rule Published 3/9/2011]",Supporting & Related Material,N-Notice (Supporting and Related Material),2011-03-10T05:00:00Z,2011,3,,,2011-03-10T22:18:25Z,,0,0,0900006480c05681
FDA-1981-N-0012-0049,FDA,FDA-1981-N-0012,"Reference 13 - Summary Minutes of the 11th meeting of the Advisory Review Panel on OTC Miscellaneous  Internal Drug Products held on May 9-10, 1976, OTC Vol. 170010 [Notice of Proposed Rule Published 3/9/2011]",Supporting & Related Material,N-Notice (Supporting and Related Material),2011-03-10T05:00:00Z,2011,3,,,2011-03-10T22:54:20Z,,0,0,0900006480c056b2
FDA-1981-N-0012-0044,FDA,FDA-1981-N-0012,Weight Control Drug Products for Over-the-Counter Human Use: Benzocaine; Status Change,Proposed Rule,NPR-Notice of Proposed Rule-Making,2011-03-09T05:00:00Z,2011,3,2011-03-09T05:00:00Z,2011-06-08T03:59:59Z,2011-06-11T16:25:42Z,2011-05145,0,0,0900006480c03fb5
FDA-1981-N-0012-0043,FDA,FDA-1981-N-0012,"Thompson Medical Company, Inc. - Protocol Review",Other,PR-Protocol Review,2011-02-28T05:00:00Z,2011,2,2011-02-28T05:00:00Z,,2011-02-28T17:43:27Z,,0,0,09000064805ae84c
FDA-1981-N-0012-0040,FDA,FDA-1981-N-0012,"FDA/HFD-210 to Thompson Medical Company, Inc. - Letter",Other,LET-Letter,2011-02-28T05:00:00Z,2011,2,2011-02-28T05:00:00Z,,2011-02-28T17:35:08Z,,0,0,09000064805ae732
FDA-1981-N-0012-0033,FDA,FDA-1981-N-0012,"Tab B - Weight Control Drug Products For Over-The Counter Human Use; Certain Active Ingredients: Final Rule Federal Register Vol 56, No. 153. 21 CFR Part 310 - [Thompson Medical Company, Inc.- Citizen Petition]",Other,CP-Citizen Petition,2011-02-28T05:00:00Z,2011,2,2011-02-28T05:00:00Z,,2011-02-28T17:28:29Z,,0,0,09000064805ae82d
FDA-1981-N-0012-0041,FDA,FDA-1981-N-0012,"FDA/HFD-210 to Thompson Medical Company, Inc. - Letter",Other,LET-Letter,2011-02-28T05:00:00Z,2011,2,2011-02-28T05:00:00Z,,2011-02-28T17:38:23Z,,0,0,09000064805ae823